Program Operations Bureau

Revised Guidance for Civil Money Penalty Reinvestment Projects 5.12.21

COVID-19 Testing Guidance for Home Health and Hospice Providers

SARS-CoV-2 virus Guidance for Long-Term Care Providers and administrators Sept 28,2020

COVID-19 Testing Guidance for Assisted Living Facilities

New Mexico Nurse Aide Training and Registry Reciprocity Form

Nurse Aide Registry Test Fee Rates

This document describes the process for requesting an informal dispute resolution hearing.

These are the official policies and procedures for the independent informal dispute resolution process.

Live Blood Cell Analysis is a test which is used for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or assessment of the health of human beings. The Health Care Financing Administration (now the Centers for Medicare & Medicaid Services) Office of General Counsel determined in August, 1997, that Live Blood Cell Analysis was subject to all Clinical Laboratory Improvement Act requirements.

The Clinical Laboratory Improvement Act began in the late 1960's when problems arose in the cytology laboratories that read PAP smears. The personnel in these laboratories were overworked and had a very high error rate. In 1967, the Clinical Laboratory Improvement Amendment was passed and the first laboratory regulations were born. These regulations primarily covered independent and hospital laboratories.

Use this form to request an independent informal dispute resolution hearing.